NCT06709729View on ClinicalTrials.gov

Switch of AndroidAPS to Commercially Available AID Systems

NAActive, not recruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 1, 2024

Study Completion Date

December 31, 2024

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Insulin pump with closed-loop system

Device: Usage of Insulin pump t:slim X2 with Control-IQ technology or MiniMed 780G with Smartguard technology in previous users of AndroidAPS

Trial Locations (1)

12808

3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague

All Listed Sponsors
collaborator

General University Hospital, Prague

OTHER

lead

Charles University, Czech Republic

OTHER